← Back
$JNJ All transactions

JOHNSON & JOHNSON

▼ SELL

$ Value

$10.8M

Shares

48,782

Price

$221

Filed

Jan 28

Insider

Name

Duato Joaquin

Title

CEO and Chairman of the Board

CIK

0001673401

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-26

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

30,852

Footnotes

This transaction was executed in multiple trades at prices ranging from $220.39 to $221.376. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $221.38 to $221.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (12/31/2025).

Filing Info

Accession No.

0000200406-26-000004

Form Type

4

Issuer CIK

0000200406

Duato Joaquin's History

Date Ticker Type Value
2026-02-15 JNJ M $0
2026-02-15 JNJ F $390K
2026-02-15 JNJ M $0
2026-02-15 JNJ F $477K
2026-02-15 JNJ M $0
2026-02-15 JNJ M $0
2026-02-15 JNJ A $0
2026-02-15 JNJ A $0
2026-02-13 JNJ M $0
2026-02-13 JNJ F $242K

Other Insiders at JNJ (90d)

Insider Bought Sold Last
REED JOHN C
EVP, Innovative Medicine, R&D
$13.1M 2026-02-17
Duato Joaquin
CEO and Chairman of the Board
$11.3M 2026-02-15
Wolk Joseph J
Exec VP, CFO
$21.8M 2026-02-17
Taubert Jennifer L
EVP, WWC. Innovative Medicine
2026-02-15
Wengel Kathryn E
EVP, Chief TO and Risk Officer
2026-02-15
Decker Robert J
VP Corporate Controller
2026-02-15
Swanson James D.
EVP, CIO
$15.1M 2026-02-17
Broadhurst Vanessa
EVP, Global Corp Affairs
$1.5M 2026-02-17
Forminard Elizabeth
EVP, Chief Legal Officer
2026-02-15
Schmid Timothy
EVP, WW Chair, MedTech
$5.5M 2026-02-18
Mulholland Kristen
EVP, Chief HR Officer
2026-02-15